Page last updated: 2024-10-23

bromisovalum and Alzheimer Disease

bromisovalum has been researched along with Alzheimer Disease in 1 studies

Bromisovalum: A sedative and mild hypnotic with potentially toxic effects.
bromisoval : A racemate comprising equimolar amounts of (R)- and (S)-bromisoval. It was previously used for its hypnotic and sedative properties but the use of bromides is now deprecated due to the possibility of the toxic accumulation of bromine in the body.
2-bromo-N-carbamoyl-3-methylbutanamide : An N-acylurea that is urea in which one of the hydrogens is replaced by a 2-bromo-3-methybutanoyl group.

Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Tsakiri, EN1
Gumeni, S1
Manola, MS1
Trougakos, IP1

Other Studies

1 other study available for bromisovalum and Alzheimer Disease

ArticleYear
Amyloid toxicity in a Drosophila Alzheimer's model is ameliorated by autophagy activation.
    Neurobiology of aging, 2021, Volume: 105

    Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Autophagy; Bromisovalum; Disease Models,

2021